About
RareCan provides tumour genomic analysis and genetic testing and offers personalised clinical trial navigation and recruitment support for people with rare or less common cancers in the UK. It also operates a patient BioResource with consent-to-contact capabilities and access to biosamples and genetics to support trial matching and research.
Explore RareCan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.